Filing Details
- Accession Number:
- 0001209191-14-071984
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-01 17:18:44
- Reporting Period:
- 2014-11-28
- Filing Date:
- 2014-12-01
- Accepted Time:
- 2014-12-01 17:18:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1596946 | Quotient Ltd | QTNT | In Vitro & In Vivo Diagnostic Substances (2835) | 264719797 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1409103 | Galen Partners V Lp | 680 Washington Blvd. Stamford CT 06901 | No | No | Yes | No | |
1409104 | Galen Partners International V Lp | 680 Washington Blvd. Stamford CT 06901 | No | No | Yes | No | |
1421162 | Galen Management, Llc | 680 Washington Blvd. Stamford CT 06901 | No | No | Yes | No | |
1605684 | Galen Partners V, L.l.c. | 680 Washington Blvd. Stamford CT 06901 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2014-11-28 | 157,895 | $9.50 | 5,837,397 | No | 4 | P | Indirect | See FN |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See FN |
Footnotes
- The ordinary shares were acquired in connection with the issuer's private placement. Galen Partners V LP ("Galen V") acquired 145,473 ordinary shares and Galen Partners International V LP ("Galen International V") acquired 12,422 ordinary shares.
- Includes 5,239,293 ordinary shares held of record by Galen V, 447,400 ordinary shares held of record by Galen International V and 150,704 ordinary shares held of record by Galen Management, LLC. Galen Parnters V, L.L.C. serves as the sole General Partner of Galen V and Galen International V and has sole voting and investment control over the shares held by such funds and may be deemed to beneficially own the shares held by such funds. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein, except to the extent of its respective pecuniary interest therein.